hot topics in rheumatology
DESCRIPTION
Hot Topics in Rheumatology. Prof. MG Molloy. Overview. Rheumatoid Arthritis Psoriatic Arthritis Vasculitides: SLE Osteoarthritis Osteoporosis. Rheumatoid arthritis. RA is a condition involving inflammation of the joints It has the potential to result in serious joint damage - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/1.jpg)
Hot Topics in Hot Topics in RheumatologyRheumatology
Prof. MG Molloy
![Page 2: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/2.jpg)
OverviewOverview
• Rheumatoid Arthritis
• Psoriatic Arthritis• Vasculitides: SLE• Osteoarthritis• Osteoporosis
![Page 3: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/3.jpg)
Rheumatoid arthritisRheumatoid arthritis
– RA is a condition involving inflammation of the joints• It has the potential to result in serious joint
damage• It may come on suddenly or appear slowly
over time• Its symptoms may include pain, swelling,
stiffness in the joints, and general tiredness
![Page 4: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/4.jpg)
Rheumatoid ArthritisRheumatoid Arthritis• Damage occurs early in most patients
• 50% show joint space narrowing or erosions in the first 2 years
• By 10 years, 50% of young working patients are disabled
• Death comes early• Multiple causes• Compared to general population
• Women lose 10 years, men lose 4 years
![Page 5: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/5.jpg)
Who is affected by RA?Who is affected by RA?
– RA is one of the most common forms of inflammatory arthritis
• Affects about 1% of the world’s population
• Occurs 2 to 3 times more often in women than in men
• In most cases it develops between the ages of 25 and 50
![Page 6: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/6.jpg)
RA: Multisystem diseaseRA: Multisystem disease
• Extra-articular:– Cardiac
• coronary heart disease
– Pulmonary• fibrosis
– Haematological• Anaemia
– Ophthalmology– Dermatology– Renal
![Page 7: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/7.jpg)
Cardiac disease in RACardiac disease in RA
• Mortality in RA is unchanged in 40yrs despite DMARDS
• Patients unlikely to report symptoms of angina
• Not all IHD risk is due to traditional risk factors nor drugs such as Pred use, HRT DM etc
• Control BP, cholesterol etc
• High index of suspicion: cardiology referral
![Page 8: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/8.jpg)
Management RAManagement RA
![Page 9: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/9.jpg)
Medications for RAMedications for RA
• Nonsteroidal anti-inflammatory drugs (NSAIDs)
• Corticosteroids
• Disease-modifying antirheumatic drugs (DMARDs)
• Biologics
• Combination
![Page 10: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/10.jpg)
DMARD options DMARD options
• Hydroxychloroquine
• Sulphasalazine
• Methotrexate
• Azathioprine • Slow onset, reasonably effective
• Leflunomide• Pyrimidine inhibitor• Effect and side effects similar to those of MTX
![Page 11: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/11.jpg)
DMARDsDMARDs Combination or monotherapy Combination or monotherapy
• No superiority of traditional combination DMARD therapy over monotherapy
• Some trials did not control for glucocorticoid use
• Review of studies since 2000 have shown that step-up therapy of Leflunomide +MTX is superior but, with significant toxicity
![Page 12: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/12.jpg)
MethotrexateMethotrexate
• Commonest DMARD• 30 year experience• Monitoring: monthly FBC, ESR, CRP,
Bioprofile, LFTs• Complications:
– Haem:Neutropenia, thrombocytopenia, ? Leukemia
– Liver dysfunction
![Page 13: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/13.jpg)
New BiologicsNew Biologics
• Infliximab ( chimeric monoclonal antibody to TNF)
• Etanercept (soluble TNF receptor)
• Adalimumab (humanised monoclonal antibody to TNF)
• Rituximab (anti-CD 20 )
• Anti-Interleukin 6 (in clinical trials for JRA)
![Page 14: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/14.jpg)
Biologic agents in RABiologic agents in RA
• Indication: Refractory RA
• Prior to commencing: CXR, Mantoux
• Contraindications/Precautions:– Previous TB, COPD, Chronic infections, HIV
![Page 15: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/15.jpg)
Biologic agents in RABiologic agents in RA• Monitoring:
– Monthly bloods: FBC, ESR, CRP, Bioprofile
– Regular physical examination
– Beware infection
• NB: Normal WCC, ESR, CRP does not exclude infection
![Page 16: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/16.jpg)
New drugs New drugs
• Rituximab (anti- CD 20)- in use• Epratuzumab anti-CD22 – better risk profile than ritux• Anti-CD4 – was good but CD4 counts dropped so low trials
stopped• Efalizumab – anti-CD11a –used in psoriasis, no good in PSA• CTLA4-Ig (in trials)- binds CD80/86 and blocks cell activation• Alefacept- binds LFA-3• Anti-RANKL• SOCS• IL1-trap• Anti-IL6 receptor antibody• Soluble IL-15 receptor antagonist – 62% ACR 20 scores in high
dose group• Other targets – IL-12, IL-17, IL-18, IL-23, IL-27,IFN alpha and
gamma
![Page 17: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/17.jpg)
Summary RA Summary RA RA – early treatment = better outcome MTX good monotherapy in many patients Combo therapy of traditional DMARDs is possibly
superior but conflicting studies
Biologics =higher expectations Currently combo biologics +MTX better than biologic
monotherapy Are biologics capable of inducing remission in early
disease – then do we switch to mainteance therapy with MTX – unknown yet
Anti – CCP antibody - predictor of erosive disease course
![Page 18: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/18.jpg)
SpondyloarthropathiesSpondyloarthropathies
Ankylosing SpondylitisPsoriatic arthropathy
![Page 19: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/19.jpg)
Ank SpondAnk Spond
![Page 20: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/20.jpg)
Ank SpondAnk Spond
• Diagnosis:– Clinical: Backpain and stiffness: EMS– Age 20-40yrs male– Xray: late changes
• Treatment:– Exercises, NSAIDS– Biologics
![Page 21: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/21.jpg)
Gout & PseudogoutGout & PseudogoutCrystal arthropathiesCrystal arthropathies
![Page 22: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/22.jpg)
Gout Gout uric acid depositionuric acid deposition
• Clinical– Monoarticular– The most painful
arthropathy
• Treatment– NSAIDS– Allopurinol:
prophylaxis– Colchicine:
• Nausea, vomting, diarrhoea
![Page 23: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/23.jpg)
Pseudo-goutPseudo-gout
• 2nd, 3rd MCPs, wrists, shoulders, knees, feet
• Associations:– Haemochromatosis– Age
• Treatment– Underlying disease– NSAIDS
![Page 24: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/24.jpg)
VasculitidesVasculitides
SLE
![Page 25: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/25.jpg)
SLESLE
![Page 26: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/26.jpg)
Management of SLEManagement of SLE
![Page 27: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/27.jpg)
OsteoarthritisOsteoarthritis
![Page 28: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/28.jpg)
OsteoarthritisOsteoarthritis
![Page 29: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/29.jpg)
OsteoporosisOsteoporosis
![Page 30: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/30.jpg)
Osteoporosis Osteoporosis
• Diagnosis
![Page 31: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/31.jpg)
Osteoporosis Osteoporosis
• Management
![Page 32: Hot Topics in Rheumatology](https://reader035.vdocuments.mx/reader035/viewer/2022062309/56815914550346895dc63ef9/html5/thumbnails/32.jpg)
ThankyouThankyou